Linking molecular therapeutics to molecular diagnostics: Inhibition of the FRAP/RAFT/TOR component of the PI3K pathway preferentially blocks PTEN mutant cells <i>in vitro</i> and <i>in vivo</i>
Linking molecular therapeutics to molecular diagnostics: Inhibition of the FRAP/RAFT/TOR...
Mills, Gordon B.;Lu, Yiling;Kohn, Elise C.
2001-08-28 00:00:00
http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.pngProceedings of the National Academy of SciencesUnpaywallhttp://www.deepdyve.com/lp/unpaywall/linking-molecular-therapeutics-to-molecular-diagnostics-inhibition-of-N2wtqUCU5v
Linking molecular therapeutics to molecular diagnostics: Inhibition of the FRAP/RAFT/TOR component of the PI3K pathway preferentially blocks PTEN mutant cells <i>in vitro</i> and <i>in vivo</i>
Linking molecular therapeutics to molecular diagnostics: Inhibition of the FRAP/RAFT/TOR component of the PI3K pathway preferentially blocks PTEN mutant cells <i>in vitro</i> and <i>in vivo</i>
To get new article updates from a journal on your personalized homepage, please log in first, or sign up for a DeepDyve account if you don’t already have one.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.